Clinical Trial Search Results

  • CRD3003 - IMUNITI
    Keywords: CNTO1275CRD3003: A phase 3, randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the safety and efficacy of Ustekinumab maintenance therapy in subjects with moderately to severely active crohn's disease.
    Specialties: Gastroenterology, Irritable Bowel Syndrome,
    Status: Active, not recruiting Principal Investigator: Kathryn Peterson
  • The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study
    Keywords: Irritable Bowel Syndrome, Diarrhea, Mesalamine, Gastroenteritis, abdominal pain, hypersensitivity
    Specialties: Gastroenterology,Gastroenterology, ,Irritable Bowel Syndrome,
    Status: Recruiting Principal Investigator: Ashok Tuteja

Search for Trials

Trials By Name A to Z

Trials by Department, Division or Specialty

Related Links